Incidence and Risk Factors for Metabolic Syndrome in Korean Male Workers, Ages 30 to 39

Annals of Epidemiology

Volumn 17, Issue 4, 2007, Pages 245-252

  Ryu, Seungho ^a   Song, Jaechul ^a   Choi, Bo Youl ^a   Lee, Soo Jin ^a   Kim, Won Sool ^a   Chang, YooSoo ^a   Kim, Dong IL ^a   Suh, Byung Seong ^a   Sung, KI Chul ^a  

^a Public Health Center   (South Korea)

Author keywords

Incidence Density; Metabolic Syndrome; Prospective Cohort Study; Risk Factors

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; URIC ACID;

ADULT; ARTICLE; BODY MASS; CLINICAL EXAMINATION; COHORT ANALYSIS; CONFIDENCE INTERVAL; DYSLIPIDEMIA; FOLLOW UP; GROUPS BY AGE; HEALTH PROGRAM; HUMAN; INCIDENCE; KOREA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; UNIVERSITY HOSPITAL; WAIST CIRCUMFERENCE; WEIGHT CHANGE; WORKER;

ADULT; COHORT STUDIES; HUMANS; KOREA; MALE; METABOLIC SYNDROME X; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 33947369055     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2006.10.001     Document Type: Article

References (30)

1. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus (1999), World Health Organization, Geneva
2. Balkau B., and Charles M.A. Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16 (1999) 442-443
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NECP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
4. Lorenzo C., Okoloise M., Williams K., Stern M.P., and Haffner S.M. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 26 (2003) 3153-3159
5. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., and Salonen J.T. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
6. Lorenzo C., Serrano-Rios M., Martinez-Larrad M.T., Gabriel R., Williams K., Gomez-Gerique J.A., et al. Central adiposity determines prevalence differences of the metabolic syndrome. Obes Res 11 (2003) 1480-1487
7. Ford E.S., Giles W.H., and Mokdad A.H. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 27 (2004) 2444-2449
8. Lim S., Park K.S., Lee H.K., and Cho S.I. Korean National Health and Nutrition Examination Surveys. Changes in the characteristics of metabolic syndrome in Korea over the period 1998-2001 as determined by Korean National Health and Nutrition Examination Surveys. Diabetes Care 28 (2005) 1810-1812
9. WHO Western Pacific Region, IASO and IOTF. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment (2000), Health Communications Australia Pty Limit, Sydney, Australia
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
11. Nakanishi N., Suzuki K., and Tatara K. Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 27 (2004) 1427-1432
12. Korean National Statistical Office. Annual Report on the Vital Statistics in Seoul, Korea (1990-2001), Korean National Statistical Office, Seoul, Korea
13. Korean Institute for Health and Social Affairs. The report of the Korean Nationwide Health and Nutritional Examination Survey in 2001-2003.
14. Reaven G. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation 106 (2002) 286-288
15. Modan M., Halkin H., Karasik A., and Lusky A. Elevated serum uric acid: a facet of hyperinsulinaemia. Diabetologia 30 (1987) 713-718
16. Selby J.V., Friedman G.D., and Quesenberry Jr. C.P. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 131 (1990) 1017-1027
17. Zavaroni I., Mazza S., Fantuzzi M., Dall'Aglio E., Bonora E., Delsignore R., et al. Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia. J Intern Med 234 (1993) 25-30
18. Folsom A.R., Burke G.L., Ballew C., Jacobs Jr. D.R., Haskell W.L., Donahue R.P., et al. Relation of body fatness and its distribution to cardiovascular risk factors in young blacks and whites: the role of insulin. Am J Epidemiol 130 (1989) 911-924
19. Krotkiewski M., Bjorntorp P., Sjostrom L., and Smith U. Impact of obesity on metabolism in men and women: importance of regional adipose tissue distribution. J Clin Invest 72 (1983) 1150-1162
20. Wei M., Gaskill S.P., Haffner S.M., and Stern M.P. Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans: a 7-year prospective study. Obes Res 5 (1997) 16-23
21. Stevens J., Couper D., Pankow J., Folsom A.R., Duncan B.B., Nieto F.J., et al. Sensitivity and specificity of anthropometrics for the prediction of diabetes in a biracial cohort. Obes Res 9 (2001) 696-705
22. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation 107 (2003) 391-397
23. Sattar N., Gaw A., Scherbakova O., Ford I., O'Reilly D.S., Haffner S.M., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 (2003) 414-419
24. Anderson J.W., Gustafson N.J., Bryant C.A., and Tietyen-Clark J. Dietary fiber and diabetes: a comprehensive review and practical application. J Am Diet Assoc 87 (1987) 1189-1197
25. Mayer E.J., Newman B., Quesenberry Jr. C.P., and Selby J.V. Usual dietary fat intake and insulin concentrations in healthy women twins. Diabetes Care 16 (1993) 1459-1469
26. Swai A.B., McLarty D.G., Kitange H.M., Kilima P.M., Masuki G., Mtinangi B.I., et al. Study in Tanzania of impaired glucose tolerance: methodological myth?. Diabetes 40 (1991) 516-520
27. Trevisan M., Liu J., Bahsas F.B., and Menotti A. Syndrome X and mortality: a population-based study: Risk Factor and Life Expectancy Research Group. Am J Epidemiol 148 (1998) 958-966
28. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
29. Ferrannini E., Haffner S.M., Mitchell B.D., and Stern M.P. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34 (1991) 416-422
30. DeFronzo R.A., and Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14 (1991) 173-194